Doctors Downplaying Drug’s Suicide Risks Attract FDA’s ScrutinyBy
Drugmaker has proposed changing warning label on suicide risk
Physicians receiving Pfizer money reported fewer side effects
The U.S. Food and Drug Administration has a message for doctors: The money you’re taking from pharmaceutical companies may be clouding your judgment.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.